Modulation of MicroRNA Cluster miR-183-96-182 Expression by Epstein-Barr Virus Latent Membrane Protein 1

Abstract

Epstein-Barr virus (EBV)is an oncogenic human herpesvirus involved in the pathogenesis of Burkitt's lymphoma (BL) and various other lymphoproliferative disorders. In BL, EBV protein expression is restricted to EBV nuclear antigen 1 (EBNA1), but small noncoding RNAs such as EBV-encoded small RNAs (EBERs) and microRNAs (miRNAs) can also be detected. miRNAs play major roles in crucial processes such as proliferation, differentiation, and cell death. It has recently become clear that alterations in the expression profile of miRNAs contribute to the pathogenesis of a number of malignancies. During latent infection, EBV expresses 25 viral pre-miRNAs and modulates the expression of specific cellular miRNAs, such as miR-155 and miR-146, which potentially play a role in oncogenesis. Here, we established the small-RNA expression profiles of three BL cell lines. Using largescale sequencing coupled to Northern blotting and real-time reverse transcription-PCR (RT-PCR) analysis validation, we demonstrated the differential expression of some cellular and viral miRNAs. High-level expression of the miR-183-96-182 cluster and EBV miR-BamHI A rightward transcript (miR-BART) cluster was significantly associated with EBV type I latency. This expression was not affected by viral reactivation since transforming growth factor ␤1 (TGF-␤1) stimulation did not significantly change the miRNA profiles. However, using several approaches, including de novo infection with a mutant virus, we present evidence that the expression of latent membrane protein 1 (LMP-1) triggered downregulation of the expression of the miR-183-96-182 cluster. We further show that this effect involves the Akt signaling pathway. IMPORTANCEIn addition to expressing their own miRNAs, herpesviruses also impact the expression levels of cellular miRNAs. This regulation can be either positive or negative and usually results in the perturbation of pathways to create a cellular environment that is more "virus-friendly." For example, EBV induces the expression of miR-155, a well-characterized oncomiR, which leads to increased cell proliferation and decreased cell death. Here, we show that EBV-encoded LMP-1 is also involved in the downregulation of a cluster of three miRNAs, miR-183, -96, and -182, which are known to be also repressed in several cancers. We therefore identify yet another potential player in EBV-induced oncogenesis. M ore than 90% of adults worldwide are infected with the Epstein-Barr virus (EBV), a member of the herpesvirus family (1). EBV is linked to the development of various lymphocyte malignancies, including Burkitt's lymphoma (BL), Hodgkin disease (HD), NK/T tumors, and lymphoproliferations linked to immunosuppression, including posttransplant lymphoproliferative disorders (PTLD) and AIDS-associated lymphomas (2). EBV mostly establishes a latent infection in its target cells. The expression pattern of latent genes allows distinguishing among three different latency types termed latency I to latency III. Latency III is characterized by the expressi...

Natalizumab Therapy Modulates miR-155, miR-26a and Proinflammatory Cytokine Expression in MS Patients

“…We reported a higher serum prevalence of EBNA-1 IgG in MS patients with high levels of miRNA-155. This data was confirmed by other groups that showed the ability of EBV to induce the expression of miR-155 [ 31 ], during latent infection mediated by EBNA1 and LMP, indeed EBV is able to modulate the expression of specific cellular miRNAs, such as miR-155 and miR-146 [ 31 ]. Previous work did not show that natalizumab therapy was able to modify the immune response against EBNA1 in MS patients [ 32 , 33 ].…”

Viral Ubiquitin Ligase Stimulates Selective Host MicroRNA Expression by Targeting ZEB Transcriptional Repressors

“…During type II and III latency, the γ-herpesvirus EBV selectively downregulates miR-183/96/182 expression [ 114 , 115 , 116 ]. This is mediated by the viral latent membrane protein I (LMP-1), the major oncoprotein of EBV [ 114 ].…”

“…During type II and III latency, the γ-herpesvirus EBV selectively downregulates miR-183/96/182 expression [ 114 , 115 , 116 ]. This is mediated by the viral latent membrane protein I (LMP-1), the major oncoprotein of EBV [ 114 ]. Reduced miR-183/96/182 expression helps push EBV-infected B-lymphocytes and epithelial cells towards a more mesenchymal phenotype, although additional viral and host miRNAs contribute to this phenotypic shift [ 117 , 118 ].…”

On the Importance of Host MicroRNAs During Viral Infection

“…The use of small RNA cloning and sequencing has been employed in several recent studies to identify up- or down-regulated miRNA upon infection with different viruses ( Motsch et al, 2012 ; Oussaief et al, 2015 ; Chen et al, 2016 ; Lodge et al, 2017 ). However, these studies did not necessarily confirm whether the regulated miRNAs were having pro- or anti-viral roles.…”